Market capitalization | $133.56b |
Enterprise Value | $152.06b |
P/E (TTM) P/E ratio | 29.22 |
EV/FCF (TTM) EV/FCF | 25.81 |
EV/Sales (TTM) EV/Sales | 3.19 |
P/S ratio (TTM) P/S ratio | 2.80 |
P/B ratio (TTM) P/B ratio | 1.71 |
Dividend yield | 3.82% |
Last dividend (FY24) | $2.04 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
21 Analysts have issued a Sanofi Sponsored ADR forecast:
21 Analysts have issued a Sanofi Sponsored ADR forecast:
Jun '24 |
+/-
%
|
||
Revenue | 47,675 47,675 |
5%
5%
|
|
Gross Profit | 29,304 29,304 |
3%
3%
|
|
EBITDA | 14,951 14,951 |
8%
8%
|
EBIT (Operating Income) EBIT | 10,136 10,136 |
1%
1%
|
Net Profit | 4,558 4,558 |
49%
49%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Head office | France |
CEO | Paul Hudson |
Employees | 87,994 |
Founded | 1994 |
Website | www.sanofi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.